Hydroxamamide as a chelating moiety for the preparation of 99mTc-radiopharmaceuticals III. Characterization of various 99mTc-hydroxamamides-Reference-Cited by-同舟云学术

Hydroxamamide as a chelating moiety for the preparation of 99mTc-radiopharmaceuticals III. Characterization of various 99mTc-hydroxamamides

Published:1997-05 Issue:5 Volume:48 Page:571-577
ISSN:0969-8043
Container-title:Applied Radiation and Isotopes
language:en
Short-container-title:Applied Radiation and Isotopes

Author:

Nakayama M.,Xu L.C.,Koga Y.,Harada K.,Sugii A.,Nakayama H.,Tomiguchi S.,Kojima A.,Ohyama Y.,Takahashi M.,Okabayashi I.

Publisher

Elsevier BV

Subject

Radiation

Reference14 articles.

1. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats;Abrams;Journal of Nuclear Medicine,1990

2. Synthesis and evaluation of a new bifunctional chelating agent for 99mTc labeling proteins: p-carboxyethylphenylglyoxal-di(N-methylthiosemicarbazone);Arano;International Journal of Nuclear Medicine and Biology,1986

3. The chemistry of amidoxines and related compounds;Eloy;Chemistry Review,1962

4. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement;Fritzberg;Journal of Nuclear Medicine,1986

5. Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations;Jones;International Journal of Nuclear Medicine and Biology,1984

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer;Annals of Nuclear Medicine;2024-07-08

2. Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer;2024-06-05

3. Development of a hydroxamamide-based bifunctional chelating agent to prepare technetium-99m-labeled bivalent ligand probes;Scientific Reports;2021-09-21

4. Synthesis and evaluation of novel technetium-99m-hydroxamamide complex based on imidazothiadiazole sulfonamide targeting carbonic anhydrase-IX for tumor imaging;Bioorganic & Medicinal Chemistry Letters;2020-11

5. 99mTc Labelling Strategies for the Development of Potential Nitroimidazolic Hypoxia Imaging Agents;Inorganics;2019-10-23